DARU-Journal of Pharmaceutical Sciences
Scope & Guideline
Bridging research and practice in pharmaceutical sciences.
Introduction
Aims and Scopes
- Drug Development and Delivery Systems:
Focuses on innovative methods for drug formulation and delivery, including nanotechnology, hydrogels, and polymeric systems to enhance therapeutic efficacy. - Pharmacology and Therapeutics:
Explores the pharmacokinetics, pharmacodynamics, and therapeutic applications of various drugs, with an emphasis on both traditional and novel agents. - Toxicology and Safety Assessment:
Covers studies on drug toxicity, adverse effects, and safety evaluations, including environmental impacts of pharmaceuticals and assessments of pharmaceutical contaminants. - Natural Products and Ethnopharmacology:
Investigates the pharmacological properties of natural products and traditional medicines, with a focus on their potential therapeutic applications and mechanisms of action. - Clinical and Translational Research:
Encourages research that bridges laboratory findings with clinical applications, including trials, observational studies, and meta-analyses that inform clinical practice. - Artificial Intelligence and Computational Methods:
Utilizes AI and computational techniques for drug discovery, prediction of drug interactions, and development of predictive models in pharmacotherapy.
Trending and Emerging
- Nanotechnology in Drug Delivery:
An increasing number of publications focus on the use of nanocarriers for drug delivery, highlighting their potential to improve bioavailability and targeted therapy. - Pharmacogenomics and Personalized Medicine:
There is a growing emphasis on pharmacogenomics, exploring how genetic variations affect drug responses, paving the way for personalized therapeutic strategies. - Artificial Intelligence and Machine Learning Applications:
The integration of AI and machine learning in drug discovery, patient monitoring, and predicting drug interactions is gaining traction, with several studies showcasing innovative applications. - Impact of Environmental Factors on Pharmacotherapy:
Emerging research explores how environmental contaminants and drug residues affect human health and pharmacotherapy, reflecting increasing public health concerns. - Ethnopharmacology and Natural Products:
A resurgence in interest in ethnopharmacology, with studies investigating traditional medicinal plants and their bioactive compounds for potential therapeutic applications. - Drug Repurposing Strategies:
Research on repurposing existing drugs for new therapeutic uses, especially in the context of recent global health challenges (e.g., COVID-19), is becoming increasingly prominent.
Declining or Waning
- Traditional Chemical Synthesis:
Research papers focusing solely on conventional chemical synthesis methods have decreased. The journal's newer publications tend to emphasize innovative and hybrid approaches, such as bio-based synthesis and nanotechnology. - Animal Models in Drug Testing:
While animal studies remain important, there has been a noticeable reduction in papers solely relying on animal models for drug testing, with a shift towards more complex in vitro and computational models. - In vitro Studies Without Clinical Relevance:
The journal appears to be moving away from pure in vitro studies that lack a clear clinical application or relevance, favoring research that directly correlates laboratory findings with clinical implications. - Single-Agent Drug Studies:
Research focusing exclusively on the effects of single-agent drugs has waned, as there is a growing trend towards combination therapies and polypharmacy in clinical applications.
Similar Journals
Istanbul Journal of Pharmacy
Advancing pharmaceutical knowledge for a healthier tomorrow.Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.
Iranian Journal of Pharmaceutical Research
Advancing pharmaceutical knowledge for a healthier tomorrow.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
ACTA PHARMACEUTICA
Exploring the forefront of pharmaceutical and biomedical advancements.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
Research in Pharmaceutical Sciences
Fostering Excellence in Pharmaceutical ResearchResearch in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.
International Journal of Pharmaceutical Investigation
Advancing Pharmaceutical Science for a Healthier TomorrowInternational Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.
Pharmaceutical Sciences
Empowering global health through cutting-edge pharmaceutical research.Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.
PHARMACIA
Exploring the frontiers of drug development and therapeutic science.PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.
Advances in Pharmacological and Pharmaceutical Sciences
Bridging Research and Practice in Pharmaceutical Sciences.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
INDIAN JOURNAL OF PHARMACOLOGY
Connecting academia and industry to shape the future of pharmacology.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
Future Journal of Pharmaceutical Sciences
Bridging Research and Practice in the Pharmaceutical RealmThe Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.